SMTI logo

Sanara MedTech (SMTI) Company Overview

Profile

Full Name:

Sanara MedTech Inc.

Sector:

Healthcare

Country:

United States

IPO:

April 7, 1994

Indexes:

Not included

Description:

Sanara MedTech Inc. (SMTI) focuses on developing and commercializing advanced medical technologies. The company specializes in innovative wound care and regenerative medicine products, aiming to improve patient outcomes and enhance healing processes. SMTI collaborates with healthcare professionals to provide effective solutions for various medical needs.

Key Details

Price

$34.59

Annual Revenue

$64.99 M(+41.77% YoY)

Annual EPS

-$0.52(+48.00% YoY)

Beta

2.01

Events Calendar

Earnings

Next earnings date:

Mar 25, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 25, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 10, 2019

Analyst ratings

Recent major analysts updates

Jan 23, 25 HC Wainwright & Co.
Buy
Jan 23, 25 Cantor Fitzgerald
Overweight
Jan 22, 25 Cantor Fitzgerald
Overweight
Dec 23, 24 HC Wainwright & Co.
Buy
May 15, 24 Cantor Fitzgerald
Overweight
Mar 27, 24 Cantor Fitzgerald
Overweight
Feb 6, 24 Cantor Fitzgerald
Overweight
Nov 15, 23 Cantor Fitzgerald
Overweight
Sep 26, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
SMTI
globenewswire.comJanuary 21, 2025

OsStic ® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually ( 1) ; arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
SMTI
globenewswire.comJanuary 21, 2025

Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
SMTI
globenewswire.comNovember 25, 2024

FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company's Chairman and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference, which is being held at The Lotte New York Palace in New York, NY from December 3 – 5, 2024. Mr. Nixon will deliver a presentation to investors on Wednesday, December 4 at approximately 11:50 a.m. Eastern Time.

All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy
All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy
All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy
SMTI
zacks.comNovember 19, 2024

Sanara MedTech (SMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript
SMTI
seekingalpha.comNovember 13, 2024

Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Michael McNeil - Chief Financial Officer Sam Muppalla - Tissue Health Plus Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCapClub Chris Plahm - Tall Pines Capital John Siedhoff - Twin Oaks Equity Operator Good morning, and welcome to the Sanara MedTech Third Quarter 2024 Earnings Conference Call. The company issued its earnings release yesterday and will post today's supplemental deck on the Investor Relations page on the company's website.

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
SMTI
globenewswire.comOctober 31, 2024

FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara will issue its earnings release on Tuesday, November 12, 2024, and will host a conference call on Wednesday, November 13, 2024, at 9:00 a.m.

Sanara MedTech Inc. Announces Changes to Its Board of Directors
Sanara MedTech Inc. Announces Changes to Its Board of Directors
Sanara MedTech Inc. Announces Changes to Its Board of Directors
SMTI
globenewswire.comOctober 7, 2024

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director, and Mr. Keith Myers has been appointed to serve as a director on the Board in order to fill the vacancy resulting from Mr. Stuckert's resignation. Mr. Stuckert will continue to serve the Board as Director Emeritus.

Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript
SMTI
Seeking AlphaMay 14, 2024

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2024 Earnings Conference Call on May 14, 2024 at 9:00 AM ET with company representatives Callon Nichols, Ron Nixon, Mike McNeil, and Seth Yon. Moderator Ian Cassel from IFCM Operator. Welcome to the Sanara MedTech Inc. First Quarter Results and Business Update Conference Call. All participants are currently in a listen-only mode.

Sanara MedTech Inc. (SMTI) Q3 2023 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q3 2023 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q3 2023 Earnings Call Transcript
SMTI
Seeking AlphaNovember 14, 2023

Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2023 Results Conference Call November 14, 2023 9:00 AM ET Company Participants Callon Nichols - Vice President of Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - Chief Executive Officer Mike McNeil - CFO & Corporate Secretary Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - IFCM Niraj Gupta - GCI Partners Operator Greetings, and welcome to the Sanara MedTech Incorporated Third Quarter 2023 Results and Business Update Call. At this time, all participants are in a listen-only mode.

Sanara Medtech, Inc. (SMTI) Q2 2023 Earnings Call Transcript
Sanara Medtech, Inc. (SMTI) Q2 2023 Earnings Call Transcript
Sanara Medtech, Inc. (SMTI) Q2 2023 Earnings Call Transcript
SMTI
Seeking AlphaAugust 15, 2023

Sanara Medtech, Inc. (NASDAQ:SMTI ) Q2 2023 Earnings Conference Call August 15, 2023 9:00 AM ET Company Participants Callon Nichols - VP, Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - CEO Mike McNeil - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCap Club Operator Greetings. Welcome to the Sanara MedTech Inc. Second Quarter 2023 Results and Business Update Conference Call.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for Sanara MedTech?
  • Does Sanara MedTech pay dividends?
  • What sector is Sanara MedTech in?
  • What industry is Sanara MedTech in?
  • What country is Sanara MedTech based in?
  • When did Sanara MedTech go public?
  • Is Sanara MedTech in the S&P 500?
  • Is Sanara MedTech in the NASDAQ 100?
  • Is Sanara MedTech in the Dow Jones?
  • When was Sanara MedTech's last earnings report?
  • When does Sanara MedTech report earnings?
  • Should I buy Sanara MedTech stock now?

What is the ticker symbol for Sanara MedTech?

The ticker symbol for Sanara MedTech is NASDAQ:SMTI

Does Sanara MedTech pay dividends?

No, Sanara MedTech does not pay dividends

What sector is Sanara MedTech in?

Sanara MedTech is in the Healthcare sector

What industry is Sanara MedTech in?

Sanara MedTech is in the Medical Instruments & Supplies industry

What country is Sanara MedTech based in?

Sanara MedTech is headquartered in United States

When did Sanara MedTech go public?

Sanara MedTech's initial public offering (IPO) was on April 7, 1994

Is Sanara MedTech in the S&P 500?

No, Sanara MedTech is not included in the S&P 500 index

Is Sanara MedTech in the NASDAQ 100?

No, Sanara MedTech is not included in the NASDAQ 100 index

Is Sanara MedTech in the Dow Jones?

No, Sanara MedTech is not included in the Dow Jones index

When was Sanara MedTech's last earnings report?

Sanara MedTech's most recent earnings report was on Nov 12, 2024

When does Sanara MedTech report earnings?

The next expected earnings date for Sanara MedTech is Mar 25, 2025

Should I buy Sanara MedTech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions